HeyDoctor
Summer 2018AcquiredHeyDoctor provides online primary care (like refilling birth control,…
Pressure-test this opportunity
Explore the risks and possibilities with a prompt for ChatGPT, Claude, or your agent.
HeyDoctor provides online primary care (like refilling birth control,…
Explore the risks and possibilities with a prompt for ChatGPT, Claude, or your agent.
HeyDoctor turned a narrow set of routine medical visits into structured online questionnaires, clinician review, secure messages, prescriptions, and lab orders. A patient could start without insurance, avoid a waiting room or mandatory video call, and pay a visible cash price. The first condition menu covered birth control, urinary tract infections, acne, tobacco cessation, cold sores, and screening services.
Brendan Levy, Rohit Malhotra, and Kyle Alwyn founded the San Francisco company in 2017. HeyDoctor launched that November and joined Y Combinator's Summer 2018 batch. GoodRx acquired 100% of its legal parent, Sappira Inc., on April 18, 2019 for $14.3 million in cash.[1]
The product outlived the company. GoodRx relaunched it as HeyDoctor by GoodRx in September 2019 and renamed it GoodRx Care in 2020. In December 2022, GoodRx sold the backend technology to Wheel for $19.5 million while keeping the consumer-facing site and app. GoodRx Care still sells virtual visits. HeyDoctor's terminal event was absorption into a larger healthcare platform, followed by a separation of consumer distribution from clinical infrastructure.
Image 1 / 1
Levy was a family-medicine physician who saw patients spend hours waiting for issues that could be handled in minutes. Malhotra brought software and legal experience, while Alwyn became the company's technical co-founder. Their working premise was that common, low-complexity care did not always need an office visit or live video appointment.
The November 2017 release described a text-led service available in nineteen states. Most consultations cost less than $20, insurance was optional, and US board-certified physicians reviewed each case. The company also said it had agreements to license its electronic medical record software to enterprise customers.[2]
This was more than video medicine moved to a smaller screen. HeyDoctor divided primary care into bounded protocols: collect condition-specific history, screen for exclusions, route the case to a licensed clinician, issue a treatment plan when appropriate, and keep follow-up in messages. Prescription pickup remained local. The app made scope visible through a service catalog and prices.
The team also studied trust. A three-month user-research project interviewed ten patients seeking care for sensitive conditions. The work focused on how patients understood the process, what status information they needed, and when they expected a clinician response.[3]
HeyDoctor's patient product started with a condition menu. Each service defined eligibility, price, required questions, likely next steps, and cases that needed other care. Patients completed medical history, chose a pharmacy or lab, and exchanged secure messages with the clinical team. Prescriptions were issued only after clinician review.
GoodRx later described the acquired system as a purpose-built electronic health record with messaging, video, and electronic prescribing. That stack supported affiliated physician-owned entities and on-demand clinicians. By its 2021 filing, GoodRx said the service treated twenty-three conditions across forty-five states and operated outside insurance on a cash-pay basis.[6]
The GoodRx combination closed the loop from symptom to prescription price. A patient could receive a prescription in the visit and then apply GoodRx discounts at a pharmacy. The buyer said many consumers searched for medicine prices before they had a prescription, making clinical access a natural adjacent service.
The 2022 transaction shows what the technology became. Wheel said it bought a clinician-centered record system, clinical-management tools, and patient-experience software. Wheel had already supplied technology and clinicians to GoodRx Care since 2020. After the sale, Wheel operated the underlying platform and clinician network while GoodRx retained the consumer entry point.[7]
HeyDoctor initially served people with routine conditions who valued speed, price certainty, and privacy. The launch materials singled out students, parents, remote patients, people between insurance plans, and busy workers. Sensitive conditions made an asynchronous path especially useful because a patient could answer privately and review written instructions.
The enterprise product targeted health systems, payors, and other care organizations that needed a record and messaging layer for remote visits. Public evidence for that line is thin, so its customer count and revenue contribution are unknown.
HeyDoctor did not publish an independent market estimate. Its opportunity sat between US primary-care access, prescription fulfillment, and state-by-state telemedicine rules. GoodRx framed the acquisition around a practical funnel: medication searchers often needed a prescription before a pharmacy discount could help them.
State regulation shaped the reachable market. Federal telehealth guidance still says cross-state practice varies by state.[8] The Federation of State Medical Boards' model policy allows a physician-patient relationship to begin through synchronous or asynchronous telemedicine when the standard of care and other duties are met.[9]
HeyDoctor competed with office visits, urgent care, pharmacy clinics, and early direct-to-consumer telehealth providers. The product's distinction was a broad menu of routine care without mandatory video and with visible cash prices.
That infrastructure is now supplied by larger platforms. Wheel currently advertises more than seventy care programs, structured intake, protocol updates, credentialing, escalation, quality review, and fifty-state operations.[10] GoodRx Care competes through consumer reach and prescription savings; Wheel supplies the backend.
The direct-to-consumer model charged per visit. Most launch consultations were under $20; the GoodRx relaunch priced most visits at $20 and charged separately for lab work. The current support page lists $19 visits for Gold members and prices starting at $59.99 for non-members.[11]
Clinical revenue had corresponding physician, support, licensing, and technology costs. GoodRx's consolidated affiliated medical entities recorded $6.6 million in revenue and a $0.9 million net loss for the first nine months of 2020. The comparable 2019 period produced $0.6 million in revenue and the same net loss. Those figures document growth across post-acquisition affiliated entities and do not isolate HeyDoctor's independent economics.
The acquisition created two further forms of value. GoodRx assigned $3.1 million of the purchase accounting to developed technology and $1.1 million to trademarks and backlog. Three years later it sold selected backend assets for $19.5 million, recognized an $11.4 million pretax gain, and retained access to the service through Wheel.[12]
Public traction before the sale is limited to coverage, product breadth, enterprise claims, YC's current team-size record, and the acquisition itself. HeyDoctor reported nineteen states at launch. GoodRx later expanded the service to forty-five states and twenty-three conditions. Independent consultation volume, retention, gross margin, and funding totals were not published.
The strongest evidence is continued use. GoodRx's current UTI service preserves the structured intake, clinician conversation, prescription, and same-day pharmacy pickup that HeyDoctor introduced.[13] The original name is gone, but the care path remains commercially active.
HeyDoctor had care protocols, clinicians, and a purpose-built record. GoodRx had millions of consumers arriving with medication intent and a pharmacy-price network. The combination joined prescription creation to prescription savings. GoodRx's $14.3 million purchase price is evidence that the adjacency was worth owning before the buyer went public.
The later Wheel sale separated the asset into distribution and operations. GoodRx kept the brand, patient demand, and pharmacy connection. Wheel bought and operated the clinical technology and clinician network. This structure suggests that an independent telehealth stack faced pressure from platforms able to spread credentialing, protocols, and infrastructure across many programs.
HeyDoctor therefore did not fail as a care concept. It ceased to exist as an independent company, then its technical core moved again while the service continued. The result is a successful exit with full brand absorption.
Structured asynchronous care must encode clinical exclusions, licensure, escalation, records, and changing protocols. Privacy is part of the operating system too. HHS guidance requires regulated entities to assess tracking tools, permitted disclosures, vendor agreements, and security controls when protected health information is involved.[14]
In 2023 the FTC named GoodRx and its GoodRx Care and HeyDoctor brands in an action alleging unauthorized health-data disclosures to advertising and analytics companies. The entered order included a $1.5 million penalty, advertising restrictions, consent requirements, deletion requests, retention limits, and a privacy program.[15] The case covers the larger GoodRx organization and should not be assigned to the independent startup alone. It does show that growth, analytics, and care cannot be governed as separate systems.